Cytokine IL-12 Based Cancer Immunotherapy
DOI:
https://doi.org/10.54097/53anz541Keywords:
Cytokines; IL-12 family cytokines; Cancer immunotherapy.Abstract
Immunotherapy is an important method in cancer therapy. Cytokines are signaling molecules produced by the immune system that play a crucial role in regulating immune responses. They can be harnessed in immunotherapy to modulate the immune system's activity to treat various diseases, including cancer and autoimmune disorders. It has been confirmed that Interleukin-12 (IL-12) family cytokines play an important role in tumor immune regulation. Different cytokines in the IL-12 family have different effects and regulatory roles. The IL-12 family of cytokines has shown promise in cancer immunotherapy due to its ability to activate immune responses against tumor cells. This family includes several key cytokines, such as IL-12, Interleukin-23 (IL-23), Interleukin-27 (IL-27), and Interleukin-35 (IL-35), etc., each with distinct roles in modulating the immune system and potential applications in cancer treatment. In this review, I presented the biological functions of several types of cytokines from the IL-12 family and summarized their potential in cancer treatment.
Downloads
References
Maura Abbott, Yelena Ustoyev,Cancer and the Immune System: The History and Background of Immunotherapy,Seminars in Oncology Nursing,Volume 35, Issue 5,2019,150923,ISSN 0749-2081
Yang Y. Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest. 2015 Sep;125(9):3335-7.
Conlon KC, Miljkovic MD, Waldmann TA. Cytokines in the Treatment of Cancer. J Interferon Cytokine Res. 2019 Jan;39(1):6-21. doi: 10.1089/jir.2018.0019. Epub 2018 Jun 11.
Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017 Feb 28; 387:61-68.
Li L, Yu R, Cai T, Chen Z, Lan M, Zou T, Wang B, Wang Q, Zhao Y, Cai Y. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment. Int Immunopharmacol. 2020 Nov; 88:106939.
Teng, Michele W.L., et al. "IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune- mediated inflammatory diseases." Nature Medicine, vol. 21, no. 7, July 2015, pp. 719+.Gale Academic OneFile
Mirlekar B, Pylayeva-Gupta Y. IL-12 Family Cytokines in Cancer and Immunotherapy. Cancers (Basel). 2021 Jan 6;13(2):167.
Vignali, Dario A.A., and Vijay K. Kuchroo. "IL-12 family cytokines: immunological playmakers." Nature Immunology, vol. 13, no. 8, Aug. 2012, pp. 722+. Gale Academic OneFile
Agliardi G, Liuzzi AR, Hotblack A, De Feo D, Núñez N, Stowe CL, Friebel E, Nannini F, Rindlisbacher L, Roberts TA, Ramasawmy R, Williams IP, Siow BM, Lythgoe MF, Kalber TL, Quezada SA, Pule MA, Tugues S, Straathof K, Becher B. Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma. Nat Commun. 2021 Jan 19;12(1):444.
Zheng Y, Lu Z, Ding J, Jiang N, Wang J, Yang J, Song J, Chen H, Fang L, Li H, Tian H, Wang G, Zheng J, Chai D. Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma. Cancers (Basel). 2022 Sep 17;14(18):4512.
Chan Y, Tong BSB, Ngan PY, Au CS. Effectiveness of IL-23 Inhibitor Guselkumab in Real-World Chinese Patients with Psoriasis During a 20-Week Period. Psoriasis (Auckl). 2021 Jun 1; 11:53-58.
Jin-Qing Liu, Chengxiang Zhang, Xinfu Zhang, Jingyue Yan, Chunxi Zeng, Fatemeh Talebian, Kimberly Lynch, Weiyu Zhao, Xucheng Hou, Shi Du, Diana D. Kang, Binbin Deng, David W. McComb, Xue-Feng Bai, Yizhou Dong,Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy,Journal of Controlled Release,Volume 345,2022,Pages 306-313
Liu K, Huang A, Nie J, Tan J, Xing S, Qu Y, Jiang K. IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment. Front Immunol. 2021 May 21; 12:683332.
Gabriela Fonseca-Camarillo, Janette Furuzawa-Carballeda, Jesus K. Yamamoto-Furusho, Su1528: UP-REGULATION OF THE IL-39 (IL-23P19/EBI3) EXPRESSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE,Gastroenterology,Volume 162, Issue 7, Supplement,2022,Page S-615,ISSN 0016-5085
Ecoeur F, Weiss J, Schleeger S, Guntermann C. Lack of evidence for expression and function of IL-39 in human immune cells. PLoS One. 2020 Dec 1;15(12): e0242329.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Highlights in Science, Engineering and Technology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







